Alex Tkachenko is a seasoned executive with extensive experience in biotech and pharmaceuticals, currently serving as Chief Business Officer at EMA Wellness since January 2025. Prior roles include Entrepreneur In Residence at EcoR1 Capital, LLC, and Board Member positions at Actio Biosciences, Inc. and Aktis Oncology. Previously, Alex led BlackThorn Therapeutics as CEO, where significant achievements included securing a $40 million Series A funding and developing targeted treatments for neurobehavioral disorders. Alex also served as President of Siluria Technologies, overseeing substantial growth and innovation, and held various roles at Hana Biosciences and Genentech, where contributions included the acquisition of oncology compounds and the development of companion diagnostics strategies. Educational credentials include an MBA from Harvard Business School and a Ph.D. in Biochemistry and Molecular Biology from Rutgers Robert Wood Johnson Medical School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices